Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 46

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 46
---
6)Corresponds to 3,342,188 Company Shares to be issued to Sponsor. (7)Corresponds to 970,312 Company Shares to be issued to the Initial Sponsor. (8)Prior to Closing, the Parent expects to redeem a portion of the Parent shares held by Theo, and Theo expects to subsequently distribute a total of 1,500,000 Company Shares to between 300 and 424shareholders of Bioceres S.A. and Bioceres Group PLC so that the Company will comply with Nasdaq listing requirements. (9)Company Shares issued to Theo pursuant to the Backstop Agreement assuming that it satisfies its obligations thereunder pursuant to the subscription of 1,000,000 Company Shares at a subscription price of $10.00 per Company Share. Any Company Shares issued to Theo pursuant to the Backup Agreement will have a dilutive effect on other shareholders. See “ Certa in Agreements Related to the Business Combination — Backstop Agreement.” (10)Does not consider Company Shares that may be issued to Earlybird pursuant to the EarlyBird Engagement Letter. See “ Certain Agreements Relating to the Business Combination — EarlyBird Engagement Letter.” (11)The amount left in trust was calculated as cash held in Trust Account as of June 30, 2024, plus accrued interest receivable adjusted for reductions in the Trust Account reflecting the various redemption scenarios (based on the estimated per -shareredemption price of approximately $11.60 per share as of June 30, 2024) and gives effect to redemptions of Public Shares made after the December 2024 EGM. See “ Preliminary Proxy Statement — Compensation Received by the Sponsors — Conflicts of Interest” and “ Business of APx and Certain Information About APx — Overview.” Q:When will the Business Combination be completed? A:It is currently anticipated that the Business Combination will be consummated as soon as practicable following the Special Meeting, which is set for, 2025; however, (i) such meeting could be adjourned if the Adjournment Proposal is approved by our shareholders at the Special Meeting and we elect to adjourn the Special Meeting to a later date or dates to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, the Business Combination Proposal, the Cayman Merger Proposal and the Charter Amendment Proposal have not been approved, and (ii) the Closing will not occur until all conditions set